Pfizer, Astellas win FDA priority review for Padcev in bladder cancer with Merck’s Keytruda

Pfizer (PFE) and Astellas (ALPMF) (ALPMY) announced Monday that the FDA has granted priority review for their marketing application, which seeks U.S. approval for their antibody drug conjugate, Padcev ...
abc13

Pfizer submits initial data to FDA on its COVID-19 vaccine for kids 5-11

PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...
NBC Chicago

Pfizer Submits Data to FDA for Authorization of Covid Vaccine Booster Shot for General Population

Pfizer and BioNTech said Monday they have submitted early stage clinical trial data to the Food and Drug Administration as part of their U.S. application seeking authorization of a Covid vaccine ...
ksby

Pfizer submits Phase 1 results of COVID-19 vaccine booster trial to FDA for review

Pfizer on Monday announced it submitted data to the Food and Drug Administration regarding the results of Phase 1 trials for a potential COVID-19 vaccine booster shot. In a press release, Pfizer said ...